Vol. 9 No. 4 (2003)

DOI: https://doi.org/10.5912/jcb.v9i4

Published: 2003-06-01

Editorial

Editorial: Yin, yang and the biopharmaceutical industry

Henry I Miller
- PDF

Commentary

Opinion piece: Biotechnology's growthâ€“innovation paradox and the new model for success

Ann Baker
- PDF

Article

Life after Enron and ImClone: Special concerns for the biotechnology company

Neil H Aronson
- PDF
The key to successful collaborations: Rigorous and independent due diligence

Ian Rhodes, Craig Nelson, Gregory Berman
- PDF
Dominating global intellectual property: Overview of patentability in the USA, Europe and Japan

Thomas J Kowalski, Antonio Maschio, Samuel H Megerditchian
- PDF
Patent issues and future trends in drug development

Faiz Kermani, Pietro Bonacossa
- PDF
Strategies for building a global healthcare biotechnology company

James A Geraghty
- PDF
Regulatory Submissions Trends Survey 2002

Ellen Semple
- PDF
Marketspace: Trends in biotherapeutics

Alex K Pavlou
- PDF

Legal and Regulatory Updates

Legal and regulatory update: Voluntary withdrawal of marketing authorisations and consequences for parallel importers

John Wilkinson
- PDF
EU Financial accounts reports

David Citron
- PDF